Dynavax Technologies Aktie

17,75 $ +2,31% +0,40 $
In Euro: 14,436 € | 23.02.18 Nasdaq | Mehr Kurse »
WKN: A12EV9
ISIN: US2681582019
US-Symbol: DVAX
Typ: Aktie

Performance Dynavax Technologies Aktie

1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 17,225 $ 17,65 $ 18,55 $ 18,70 $ 3,95 $ 17,57 $
Änderung +3,05% +0,57% -4,31% -5,08% +349,37% +1,02%

Forum zur Dynavax Technologies Aktie

Kurios1: GlaxoSmithKline
10.11.17
The vaccine is an important product for Dynavax, given its potential. At present, the standard-​of-care for the hepatitis B virus is GlaxoSmithKline plc (ADR) (NYSE: GSK)'s Energix-B. This vaccine fetched GlaxoSmithKline sales of 210 million pounds or roughly $275 million for ...
iwanooze: dynavax news
28.11.14
http://www.wallstreet-​online.de/nachricht/7208949-dynavax-​regains-full-rights-to-investigational-tlr-7-9-inhibitor-dv1179-following-​expiration-of-collaboration-with-gsk

Analysen

Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

Dynavax Technologies Aktie & Unternehmen

Branche Biotechnologie
Herkunft USA
Website www.dynavax.com
Aktienanzahl 60,6 Mio. (Stand: 24.01.18)
Marktkap. 1,08 Mrd. $

Derivate zur Dynavax Technologies Aktie

Hebelprodukte (29)
Dynavax Technologies Aktie Hebelprodukte
Optionsscheine 29

Dividenden & Splits

11.11.14 Reverse Split 10:1 Frankfurt, Stuttgart, Berlin
10.11.14 Reverse Split 10:1 Nasdaq

Ähnliche Aktien

Name
last
change_rel
 
Trevena 1,41 € +6,02%
Celgene 77,81 € +1,65%
Akers Biosciences 0,40 € -7,83%
Cannabics Pharmaceuticals 0,845 € -8,35%
MannKind 2,52 € +8,15%